3.4300
-0.4900
(-12.50%)
At close: January 10 at 4:00:01 PM EST
3.4300
0.00
(0.00%)
After hours: January 10 at 7:33:03 PM EST
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| BARBARI SHARON SURREY A Director | Conversion of Exercise of derivative security | Aug 20, 2020 | 75,000 |
| BASTA STEVEN L Director | Stock Award(Grant) | Apr 3, 2020 | 536,537 |
| DOMZALSKI DAVID T Chief Executive Officer | Stock Award(Grant) | Nov 29, 2024 | 500,597 |
| HARSCH MUTYA FONTE General Counsel | Stock Award(Grant) | Dec 29, 2023 | 149,435 |
| LEPORE PATRICK G Director | Purchase | Nov 15, 2023 | 36,472 |
| PERCEPTIVE ADVISORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Sale | Aug 16, 2021 | -- |
| SAIK ANDREW Chief Financial Officer | Stock Award(Grant) | May 28, 2021 | 116,468 |
| STUART IAIN A Officer | Stock Award(Grant) | Dec 29, 2023 | 133,898 |
| WILEY MATTHEW T Officer | Stock Award(Grant) | Feb 22, 2021 | 116,970 |
| ZERONDA TYLER Chief Financial Officer | Stock Award(Grant) | Dec 29, 2023 | 131,837 |
Related Tickers
STOK Stoke Therapeutics, Inc.
9.00
+0.45%
RZLT Rezolute, Inc.
4.9000
-5.95%
LSTA Lisata Therapeutics, Inc.
3.7300
-1.84%
TRVI Trevi Therapeutics, Inc.
3.8200
-5.21%
VRDN Viridian Therapeutics, Inc.
18.20
-4.96%
OCS Oculis Holding AG
21.15
+13.10%
MRSN Mersana Therapeutics, Inc.
0.7200
-44.62%
GHRS GH Research PLC
8.57
-4.57%
CGEM Cullinan Therapeutics, Inc.
11.19
+0.54%
CLDX Celldex Therapeutics, Inc.
24.35
-8.22%